Intra-Uterine Contraceptive Devices Market – Bayer, Teva Pharmaceuticals, Mona Lisa N.V., DKT International, Egemen International, OCON Medical, Bernstein Liebhard LLP, Bersil

The key players of the Intra-Uterine Contraceptive Devices Market are making moves like product launches, joint ventures, developments, merges and accusations which is affecting the Global Intra-Uterine Contraceptive Devices Market and Medical Devices Industry as a whole and also affecting the sales, import, export, revenue and CAGR values.

We at Data Bridge Market Research take the help of Porter's Five Forces Analysis that explains what the threats of new entrants, threat of substitutes, bargaining power of customers, bargaining power of suppliers, and Industry rivalry to the organizations are.

Global Intra-Uterine Contraceptive Devices, By Product Type (Hormonal IUCD, Copper IUCD), By End-User (Hospitals, Gynecology Clinics, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Forecast to 2024

Get a Preview of the Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-intra-uterine-contraceptive-devices-market

Some of the major market players in this market are –

• Bayer AG,
• Teva Pharmaceutical Industries Ltd,
• Mona Lisa N.V.,
• DKT INTERNATIONAL,
• OCON Medical Ltd,
• Pregna International Limited,
• MedWOW Global,
• SMB Corporation of India,
• Meril Life Sciences Pvt. Ltd,
• GYNEAS,
• Melbea Innovations,
• Meril Life Sciences Pvt. Ltd,
• Melbea AG,
• Medicines360,
• ALLERGAN,
• Agile therapeutics Inc.,
• Among others.

Market Analysis:

The Market of Global Intra-Uterine Contraceptive Devices Market is expected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The major factors driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as growing awareness of contraceptive, increased rate of unplanned pregnancies, rising number of initiatives undertaken by the private firms, technological advancements and favourable insurance for IUCD’s.

Global Intra-Uterine Contraceptive Devices Market

Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly economical, effective, and safe birth control devices. Their major role is that they prevent pregnancy for a long period of time and prevent the chances of ectopic pregnancy. They are considered to be 99.0% effective in preventing pregnancy. There are two types of intrauterine devices copper-releasing intrauterine devices and progesterone-releasing intrauterine devices. Copper-releasing intrauterine device works by releasing copper. This copper enhances the inflammatory reaction in the uterus which prevents fertilization of eggs. Progesterone-releasing intrauterine device works by releasing progestin, which thickens the cervical mucus and creates the barrier to sperms.

In 2016, The U.S. Food and Drug Administration pharms approved Bayer AG’s low dose levonorgestrel-releasing intrauterine system. It marketed in the United States under the brand name KyleenaTM. Kyleena releases the lowest daily dose of the hormone levonorgestrel in an intrauterine system for up to five years. This is very effective protection against pregnancy, using the smallest T-shaped body available today.

Allergan in 2016 launched single-handed Liletta IUD inserter.

For More Details In-Depth Inquiry @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-intra-uterine-contraceptive-devices-market

Segmentation: Global Intra-Uterine Contraceptive Devices Market

The global market for intra-uterine contraceptive devices by the following sub-categories is presented

By Product Type

• Copper IUCD
• Hormonal IUCD

By End-User

• Hospitals
• Gynecology Clinics
• Community Healthcare

By Geography

• North America
• South America
• Europe
• Asia-Pacific
• Middle East and Africa

FACTORS DRIVING GROWTH IN THE GLOBAL INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET

The increased rate of unplanned pregnancies:

The rate of unintended pregnancy is increasing year after year, and the government initiatives regarding birth control and use of intra-uterine contraceptive devices in on the rise.

In 2010, at least 36.0% of pregnancies in every United States were unintended. In 2011, nearly half (45.0% or 2.8 million) of the 6.1 million pregnancies in the United States were unintended. In 2011, there were 45 the rate of unintended pregnancies was 45 per 1,000 women in an aged group between 15years –44years. According to a journal published by the lancet global health, 15·6 million abortions (14·1 million–17·3 million) occurred in India in 2015. The rate of abortion was 47 per 1000 women. 3.4 million Abortion occur in health facilities (22.0%). 11.5 million abortion abortions were done through medication (73.0%), 2.2 million abortions were surgical (14.0%).

According to national center for biotechnology information, in 2012 there were 85 million reported pregnancies, out of which 40.0% of all pregnancies were unintended. Of these, 50.0% ended in abortion, 13.0% ended in miscarriage, and 38.0% resulted in an unplanned birth.

Download Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-intra-uterine-contraceptive-devices-market

Table of Contents:

1. INTRODUCTION

2. MARKET SEGMENTATION

3. MARKET OVERVIEW

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY PRODUCT TYPE

7. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY GEOGRAPHY

7.2. NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

7.3. EUROPE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

7.4. APAC INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

7.5. SOUTH AMERICA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

8. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, COMPANY SHARE

8.1. COMPANY SHARE ANALYSIS: GLOBAL
8.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
8.3. COMPANY SHARE ANALYSIS: EUROPE
8.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC
8.5. COMPANY SHARE ANALYSIS: SOUTH AMERICA
8.6. COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

9. COMPANY PROFILES

9.1. BAYER AG

9.1.1. COMPANY OVERVIEW
9.1.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
9.1.3. REVENUE ANALYSIS
9.1.4. PRODUCT PORTFOLIO
9.1.5. RECENT DEVELOPMENTS
9.1.6. DATA BRIDGE ANALYSIS

9.2. TEVA PHARMACEUTICAL INDUSTRIES LTD.

9.2.1. COMPANY OVERVIEW
9.2.2. REVENUE ANALYSIS
9.2.3. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
9.2.4. PRODUCT PORTFOLIO
9.2.5. RECENT DEVELOPMENTS
9.2.6. DATA BRIDGE ANALYSIS

9.3. ALLERGEN PLC

9.3.1. COMPANY OVERVIEW
9.3.2. REVENUE ANALYSIS
9.3.3. PRODUCT PORTFOLIO
9.3.4. RECENT DEVELOPMENTS
9.3.5. DATA BRIDGE ANALYSIS

9.4. DKT INTERNATIONAL

9.4.1. COMPANY OVERVIEW
9.4.2. REVENUE ANALYSIS
9.4.3. PRODUCT PORTFOLIO

9.5. SMB CORPORATION

9.5.1. COMPANY OVERVIEW
9.5.2. REVENUE ANALYSIS
9.5.3. PRODUCT PORTFOLIO
9.5.4. RECENT DEVELOPMENTS
9.5.5. DATA BRIDGE ANALYSIS

9.6. OCON MEDICAL LTD.

9.6.1. COMPANY OVERVIEW
9.6.2. REVENUE ANALYSIS
9.6.3. PRODUCT PORTFOLIO
9.6.4. RECENT DEVELOPMENTS
9.6.5. DATA BRIDGE ANALYSIS

9.7. MONA LISA N.V.

9.7.1. COMPANY OVERVIEW
9.7.2. REVENUE ANALYSIS
9.7.3. PRODUCT PORTFOLIO
9.7.4. RECENT DEVELOPMENTS

9.8. MEDISAFE DISTRIBUTION INC.

9.8.1. COMPANY OVERVIEW
9.8.2. REVENUE ANALYSIS
9.8.3. PRODUCT PORTFOLIO
9.8.4. RECENT DEVELOPMENTS

10. RELATED REPORTS

Scope of the report

1. Strategic recommendations in key business sections in light of the market estimations.
2. Market share and size of all the foremost industry players
3. Strategic proposals for the new participants
4. To understand the future outlook and prospects for Global Intra-Uterine Contraceptive Devices Market analysis and forecast 2018-2024.
5. Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the trocars market

Complete Report Details @ https://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market/

Frequently Asked Questions:

• What will the market size be in 2024?
• What are the key factors driving the global market?
• What are the challenges to market growth?
• Who are the key players in the market?
• What are the market opportunities and threats faced by the key players?
• What will be the growth rate in 2024?
• Which strategies are used by top players in the Global Intra-Uterine Contraceptive Devices Market?

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.